Cite
Hepatitis B-surface antigen (HBsAg) vaccine fabricated chitosan-polyethylene glycol nanocomposite (HBsAg-CS-PEG- NC) preparation, immunogenicity, controlled release pattern, biocompatibility or non-target toxicity.
MLA
S, Karthick Raja Namasivayam, et al. “Hepatitis B-Surface Antigen (HBsAg) Vaccine Fabricated Chitosan-Polyethylene Glycol Nanocomposite (HBsAg-CS-PEG- NC) Preparation, Immunogenicity, Controlled Release Pattern, Biocompatibility or Non-Target Toxicity.” International Journal of Biological Macromolecules, vol. 144, Feb. 2020, pp. 978–94. EBSCOhost, https://doi.org/10.1016/j.ijbiomac.2019.09.175.
APA
S, K. R. N., Nishanth, A. N., R S, A. B., Nivedh, K., Syed, N. H., & R, R. S. (2020). Hepatitis B-surface antigen (HBsAg) vaccine fabricated chitosan-polyethylene glycol nanocomposite (HBsAg-CS-PEG- NC) preparation, immunogenicity, controlled release pattern, biocompatibility or non-target toxicity. International Journal of Biological Macromolecules, 144, 978–994. https://doi.org/10.1016/j.ijbiomac.2019.09.175
Chicago
S, Karthick Raja Namasivayam, A N Nishanth, Arvind Bharani R S, Kiran Nivedh, Nawaz Hussain Syed, and Rosario Samuel R. 2020. “Hepatitis B-Surface Antigen (HBsAg) Vaccine Fabricated Chitosan-Polyethylene Glycol Nanocomposite (HBsAg-CS-PEG- NC) Preparation, Immunogenicity, Controlled Release Pattern, Biocompatibility or Non-Target Toxicity.” International Journal of Biological Macromolecules 144 (February): 978–94. doi:10.1016/j.ijbiomac.2019.09.175.